Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain microstructural injury occurs in patients with RRMS despite ‘no evidence of disease activity’
Asaff Harel, Dylan Sperling, Maria Petracca, et al.
Journal of Neurology Neurosurgery & Psychiatry (2018) Vol. 89, Iss. 9, pp. 977-982
Closed Access | Times Cited: 17

Showing 17 citing articles:

Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis
Cristina Granziera, Jens Wuerfel, Frederik Barkhof, et al.
Brain (2021) Vol. 144, Iss. 5, pp. 1296-1311
Open Access | Times Cited: 147
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression
Piriyankan Ananthavarathan, Nitin Sahi, Declan Chard
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 2, pp. 201-216
Open Access | Times Cited: 10
An argument for broad use of high efficacy treatments in early multiple sclerosis
James Stankiewicz, Howard L. Weiner
Neurology Neuroimmunology & Neuroinflammation (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 75
Standardization of T1w/T2w Ratio Improves Detection of Tissue Damage in Multiple Sclerosis
Graham Cooper, Carsten Finke, Claudia Chien, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 38
Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging
Svetlana Bezukladova, Jouni Tuisku, Markus Matilainen, et al.
Neurology Neuroimmunology & Neuroinflammation (2020) Vol. 7, Iss. 3
Open Access | Times Cited: 34
Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in
Jeroen Van Schependom, Kaat Guldolf, Marie D’hooghe, et al.
Translational Neurodegeneration (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 33
Lesion activity and chronic demyelination are the major determinants of brain atrophy in MS
Chenyu Wang, Michael Barnett, Con Yiannikas, et al.
Neurology Neuroimmunology & Neuroinflammation (2019) Vol. 6, Iss. 5
Open Access | Times Cited: 32
Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study
Matteo Azzimonti, Paolo Preziosa, Elisabetta Pagani, et al.
Journal of Neurology (2023) Vol. 270, Iss. 9, pp. 4296-4308
Closed Access | Times Cited: 10
“No evidence of disease activity”: Is it an aspirational therapeutic goal in multiple sclerosis?
El Najjar Mayssam, Cynthia Eid, Samia J. Khoury, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 40, pp. 101935-101935
Closed Access | Times Cited: 21
Cross-sectional and longitudinal evaluation of white matter microstructure damage and cognitive correlations by automated fibre quantification in relapsing-remitting multiple sclerosis patients
Zichun Yan, Zeyun Tan, Qiyuan Zhu, et al.
Brain Imaging and Behavior (2024) Vol. 18, Iss. 5, pp. 1019-1033
Closed Access | Times Cited: 2
Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation
Graham Cooper, Claudia Chien, Hanna Zimmermann, et al.
Multiple Sclerosis Journal (2021) Vol. 27, Iss. 14, pp. 2180-2190
Open Access | Times Cited: 14
Current knowledge on multiple sclerosis pathophysiology, disability progression assessment and treatment options, and the role of autologous hematopoietic stem cell transplantation
Georgios Gakis, Ioannis Angelopoulos, Ioannis Panagoulias, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 2, pp. 103480-103480
Closed Access | Times Cited: 5
Progressive brain microstructural damage in patients with multiple sclerosis but not in patients with neuromyelitis optica spectrum disorder: A cross-sectional and follow-up tract-based spatial statistics study
Xiaoya Chen, Neil Roberts, Qiao Zheng, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 55, pp. 103178-103178
Closed Access | Times Cited: 9
Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population
Cecilia Smith Simonsen, Heidi Øyen Flemmen, Line Broch, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 6
Stability of longitudinal DTI metrics in MS with treatment of injectables, fingolimod and dimethyl fumarate
Abdulaziz Alshehri, Oun Al‐iedani, Nikitas Koussis, et al.
The Neuroradiology Journal (2022) Vol. 36, Iss. 4, pp. 388-396
Open Access | Times Cited: 5
T1/T2 ratio: A quantitative sensitive marker of brain tissue integrity in multiple sclerosis
Salem Hannoun, Gabriel Kocevar, Pekes Codjia, et al.
Journal of Neuroimaging (2021) Vol. 32, Iss. 2, pp. 328-336
Closed Access | Times Cited: 5
Strain and sex differences in somatosensation and sociability during experimental autoimmune encephalomyelitis
Katelynn Ondek, Aida Nasirishargh, Jacquelyn R. Dayton, et al.
Brain Behavior & Immunity - Health (2021) Vol. 14, pp. 100262-100262
Open Access | Times Cited: 2
Page 1

Scroll to top